Middle East Journal of Rehabilitation and Health

Published by: Kowsar

The Prevalence of Hepatitis Delta Virus in Patients with Chronic Hepatitis B and Its Association with Risk Factors

Farahnaz Bineshian 1 and Zohreh Sharifi 2 , *
Authors Information
1 Department of Parasitology and Mycology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
2 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Article information
  • Middle East Journal of Rehabilitation and Health: 6 (1); e84112
  • Published Online: January 20, 2019
  • Article Type: Research Article
  • Received: September 9, 2018
  • Revised: January 1, 2019
  • Accepted: January 2, 2019
  • DOI: 10.5812/mejrh.84112

To Cite: Bineshian F, Sharifi Z. The Prevalence of Hepatitis Delta Virus in Patients with Chronic Hepatitis B and Its Association with Risk Factors, Middle East J Rehabil Health Stud. Online ahead of Print ; 6(1):e84112. doi: 10.5812/mejrh.84112.

Copyright © 2019, Middle East Journal of Rehabilitation and Health Studies. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: Update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010;7(1):31-40. doi: 10.1038/nrgastro.2009.205. [PubMed: 20051970].
  • 2. Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997-1003. doi: 10.1136/gut.18.12.997. [PubMed: 75123]. [PubMed Central: PMC1411847].
  • 3. Lempp FA, Ni Y, Urban S. Hepatitis delta virus: Insights into a peculiar pathogen and novel treatment options. Nat Rev Gastroenterol Hepatol. 2016;13(10):580-9. doi: 10.1038/nrgastro.2016.126. [PubMed: 27534692].
  • 4. Mirshafiee H, Mahmoodian-Shooshtari M, Sharifi Z, Hosseini SM. Genotype analysis of hepatitis delta virus from hepatitis B surface antigen-positive patients using PCR-RFLP in Tehran, Iran. Arch Iran Med. 2009;12(3):238-43. [PubMed: 19400600].
  • 5. Attaran MS, Sharifi Z, Hosseini SM, Samei S, Ataee Z. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran. APMIS. 2014;122(3):243-7. doi: 10.1111/apm.12137. [PubMed: 23879563].
  • 6. Madejon A, Romero M, Hernandez A, Garcia-Sanchez A, Sanchez-Carrillo M, Olveira A, et al. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype. World J Gastroenterol. 2016;22(11):3165-74. doi: 10.3748/wjg.v22.i11.3165. [PubMed: 27003993]. [PubMed Central: PMC4789991].
  • 7. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335-52. doi: 10.1016/j.jhep.2007.11.011. [PubMed: 18096267].
  • 8. Braga WS, de Oliveira CM, de Araujo JR, Castilho Mda C, Rocha JM, Gimaque JB, et al. Chronic HDV/HBV co-infection: Predictors of disease stage---A case series of HDV-3 patients. J Hepatol. 2014;61(6):1205-11. doi: 10.1016/j.jhep.2014.05.041. [PubMed: 24905491].
  • 9. Opaleye OO, Japhet OM, Adewumi OM, Omoruyi EC, Akanbi OA, Oluremi AS, et al. Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria. Virol J. 2016;13:61. doi: 10.1186/s12985-016-0514-6. [PubMed: 27044424]. [PubMed Central: PMC4820959].
  • 10. Alavian SM, Fallahian F, Lankarani KB. Implementing strategies for hepatitis B vaccination. Saudi J Kidney Dis Transpl. 2010;21(1):10-22. [PubMed: 20061687].
  • 11. Farci P. Delta hepatitis: An update. J Hepatol. 2003;39 Suppl 1:S212-9. doi: 10.1016/S0168-8278(03)00331-3. [PubMed: 14708706].
  • 12. Mohammad Alizadeh AH, Ranjbar M, Tehrani AS, Keramat F, Mamani M, Rezazadeh M, et al. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran. J Microbiol Immunol Infect. 2010;43(6):519-23. doi: 10.1016/S1684-1182(10)60080-1. [PubMed: 21195980].
  • 13. Hajiani E, Hashemi S, Jalali F. Seroprevalence of delta hepatitis in patients with chronic hepatitis B and its clinical impact in Khuzestan province, southwest Iran. Hepat Mon. 2009;9(4):287-92.
  • 14. Hassanjani RMR, Baiki AA, Soleymani MJ. [Prevalence of anti HDV in HBV carriers in babol during 2000-2002]. J Babol Univ Med Sci. 2004;6(1):50-4. Persian.
  • 15. Ataei B, Yazdani MR, Kalantari H, Yaran M, Nokhodian Z, Javadi AA, et al. Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases. Hepat Mon. 2011;11(4):269-72. [PubMed: 22706272]. [PubMed Central: PMC3206699].
  • 16. Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Prevalence of hepatitis D in the eastern mediterranean region: Systematic review and meta analysis. Hepat Mon. 2013;13(1). doi: 10.5812/hepatmon.8210.
  • 17. Amini N, Alavian SM, Kabir A, Saiedi Hosseini SY, Aalaei Andabili SH. Clinical features and seroepidemiology of anti-HDV antibody in patients with chronic hepatitis B virus infection in Iran: A meta-analysis. Hepat Mon. 2011;11(12):960-7. doi: 10.5812/kowsar.1735143X.805. [PubMed: 22368679]. [PubMed Central: PMC3282028].
  • 18. Barkhordari K, Zahedi MJ, Pouyandeh Ravan AR, Molaie H, Arab-zadeh S. [Prevalence and genotyping of hepatitis D Virus among HBs Ag positive patients referred to besat clinic, Kerman during 2012-2013]. J Shahid Sadoughi Univ Med Sci. 2016;24(1):83-92. Persian.
  • 19. Bakhshipour A, Mashhadi M, Mohammadi M, Nezam SK. Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan. Acta Med Iran. 2013;51(4):260-4. [PubMed: 23690107].
  • 20. Khan AU, Waqar M, Akram M, Zaib M, Wasim M, Ahmad S, et al. True prevalence of twin HDV-HBV infection in Pakistan: A molecular approach. Virol J. 2011;8:420. doi: 10.1186/1743-422X-8-420. [PubMed: 21888671]. [PubMed Central: PMC3179753].
  • 21. Alavian SM, Assari S, Manzoori-Joybari H, MoghaniLankarani M, Doroudi T, Haji-Beigi B, et al. [Frequency and risk factors of hepatitis D virus in hepatitis B patients]. Govaresh. 2005;10(1):21-6. Persian.
  • 22. Seifi SJ, Ghannad MS. A study of HDV in HBsAg positive patients in Tabriz, Northwestern Iran. Hepat Mon. 2010;10(2):110-5. [PubMed: 22312383]. [PubMed Central: PMC3270353].
  • 23. Tahaei SM, Mohebbi SR, Azimzadeh P, Behelgardi A, Sanati A, Mohammadi P, et al. Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to Taleghani Hospital, Tehran, Iran. Gastroenterol Hepatol Bed Bench. 2014;7(3):144-50. [PubMed: 25120894]. [PubMed Central: PMC4129564].
  • 24. Ziaee M, Azarkar G. Prevalence of hepatitis D virus infection among patients with chronic hepatitis B attending Birjand hepatitis clinic (east of Iran) in 2012. Hepat Mon. 2013;13(8). doi: 10.5812/hepatmon.11168.
  • 25. Sayad B, Naderi Y, Alavian SM, Najafi F, Janbakhsh A, Mansouri F, et al. Hepatitis D virus infection in Kermanshah, west of Iran: Seroprevalence and viremic infections. Gastroenterol Hepatol Bed Bench. 2018;11(2):145-52. [PubMed: 29910856]. [PubMed Central: PMC5990919].
  • 26. Keshvari M, Alavian SM, Aghaee B, Behnava B, Mahdavi M, Fesharaki MG, et al. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: A study from Hepatitis Clinic of Iranian Blood Transfusion Organization. Transfus Med. 2014;24(6):411-7. doi: 10.1111/tme.12163. [PubMed: 25523297].
  • 27. Sadeghian H, Varasteh N, Esmaeelzadeh A, Nomani H, Alimardani M, Davoodnejad M, et al. Distribution of hepatitis delta virus genotypes in mashhad, northeast iran. Jundishapur J Microbiol. 2015;8(2). e14908. doi: 10.5812/jjm.14908. [PubMed: 25793092]. [PubMed Central: PMC4353030].
  • 28. Sanou AM, Benkirane K, Tinto B, Cisse A, Sagna T, Ilboudo AK, et al. Prevalence of hepatitis B virus and hepatitis D virus coinfection in Western Burkina Faso and molecular characterization of the detected virus strains. Int J Infect Dis. 2018;70:15-9. doi: 10.1016/j.ijid.2018.02.004. [PubMed: 29432880].
  • 29. Elzouki AN, Bashir SM, Elahmer O, Elzouki I, Alkhattali F. Prevalence and risk factors of hepatitis D virus infection in patients with chronic hepatitis B infection attending the three main tertiary hospitals in Libya. Arab J Gastroenterol. 2017;18(4):216-9. doi: 10.1016/j.ajg.2017.11.003. [PubMed: 29241726].
  • 30. Rizzetto M. Hepatitis D (delta). Semin Liver Dis. 2012;32(3):193-4. doi: 10.1055/s-0032-1323625. [PubMed: 22932966].
  • 31. Luma HN, Eloumou S, Okalla C, Donfack-Sontsa O, Koumitana R, Malongue A, et al. Prevalence and characteristics of hepatitis delta virus infection in a tertiary hospital setting in Cameroon. J Clin Exp Hepatol. 2017;7(4):334-9. doi: 10.1016/j.jceh.2017.05.010. [PubMed: 29234199]. [PubMed Central: PMC5715454].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments